These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 25072069)

  • 1. WHO Global rotavirus surveillance network – a strategic review of the first 5 years (2008–2012).
    Wkly Epidemiol Rec; 2014 Jul; 89(30):340-4. PubMed ID: 25072069
    [No Abstract]   [Full Text] [Related]  

  • 2. African rotavirus surveillance network: a brief overview.
    Mwenda JM; Tate JE; Parashar UD; Mihigo R; Agócs M; Serhan F; Nshimirimana D
    Pediatr Infect Dis J; 2014 Jan; 33 Suppl 1():S6-8. PubMed ID: 24343616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Burden of rotavirus hospitalisations in young children in three paediatric hospitals in the United States determined by active surveillance compared to standard indirect methods.
    Matson DO; Staat MA; Azimi P; Itzler R; Bernstein DI; Ward RL; Dahiya R; DiNubile MJ; Barnes-Eley M; Berke T
    J Paediatr Child Health; 2012 Aug; 48(8):698-704. PubMed ID: 22530784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transitioning from clinical research to public health surveillance for new vaccine preventable diseases: the case for rotavirus gastroenteritis.
    Rani M; Roesel S
    Vaccine; 2009 Nov; 27 Suppl 5():F7-11. PubMed ID: 19931724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Invasive bacterial vaccine preventable disease sentinel hospital surveillance network: summary of a strategic review and next steps, 2008–2014.
    Wkly Epidemiol Rec; 2014 Dec; 89(49):545-50. PubMed ID: 25485342
    [No Abstract]   [Full Text] [Related]  

  • 6. Preparing for the scale-up of rotavirus vaccine introduction in Africa: establishing surveillance platforms to monitor disease burden and vaccine impact.
    Mwenda JM; Tate JE; Steele AD; Parashar UD
    Pediatr Infect Dis J; 2014 Jan; 33 Suppl 1():S1-5. PubMed ID: 24343605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rotavirus in Asia: the value of surveillance for informing decisions about the introduction of new vaccines.
    Bresee JS; Hummelman E; Nelson EA; Glass RI
    J Infect Dis; 2005 Sep; 192 Suppl 1():S1-5. PubMed ID: 16088790
    [No Abstract]   [Full Text] [Related]  

  • 8. Hospital-based surveillance to evaluate the impact of rotavirus vaccination in São Paulo, Brazil.
    Sáfadi MA; Berezin EN; Munford V; Almeida FJ; de Moraes JC; Pinheiro CF; Racz ML
    Pediatr Infect Dis J; 2010 Nov; 29(11):1019-22. PubMed ID: 20543761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Universal mass vaccination against rotavirus gastroenteritis: impact on hospitalization rates in austrian children.
    Paulke-Korinek M; Rendi-Wagner P; Kundi M; Kronik R; Kollaritsch H
    Pediatr Infect Dis J; 2010 Apr; 29(4):319-23. PubMed ID: 19935446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Building rotavirus laboratory capacity to support the Global Rotavirus Surveillance Network.
    Wkly Epidemiol Rec; 2013 May; 88(21):217-23. PubMed ID: 23757795
    [No Abstract]   [Full Text] [Related]  

  • 11. Rotavirus vaccination.
    Bjur KA; Jacobson RM
    Minerva Pediatr; 2009 Oct; 61(5):515-21. PubMed ID: 19794377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rotavirus vaccines in Belgium: policy and impact.
    Braeckman T; Van Herck K; Raes M; Vergison A; Sabbe M; Van Damme P
    Pediatr Infect Dis J; 2011 Jan; 30(1 Suppl):S21-4. PubMed ID: 21183836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastroenteritis hospitalizations in older children and adults in the United States before and after implementation of infant rotavirus vaccination.
    Gastañaduy PA; Curns AT; Parashar UD; Lopman BA
    JAMA; 2013 Aug; 310(8):851-3. PubMed ID: 23982372
    [No Abstract]   [Full Text] [Related]  

  • 14. Rotavirus in Africa: shifting the focus to disease prevention.
    Neuzil KM; Armah GE; Parashar UD; Steele AD
    J Infect Dis; 2010 Sep; 202 Suppl():S1-4. PubMed ID: 20684687
    [No Abstract]   [Full Text] [Related]  

  • 15. Rotavirus vaccine: a welcome addition to the immunisation schedule in the UK.
    Iturriza-Gómara M; Cunliffe N
    BMJ; 2013 Apr; 346():f2347. PubMed ID: 23587749
    [No Abstract]   [Full Text] [Related]  

  • 16. Progress with the implementation of rotavirus surveillance and vaccines in countries of the WHO African Region, 2007–2016.
    Wkly Epidemiol Rec; 2017 Nov; 92(44):673-80. PubMed ID: 29106113
    [No Abstract]   [Full Text] [Related]  

  • 17. Apparent extinction of non-G2 rotavirus strains from circulation in Recife, Brazil, after the introduction of rotavirus vaccine.
    Nakagomi T; Cuevas LE; Gurgel RG; Elrokhsi SH; Belkhir YA; Abugalia M; Dove W; Montenegro FM; Correia JB; Nakagomi O; Cunliffe NA; Hart CA
    Arch Virol; 2008; 153(3):591-3. PubMed ID: 18175037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing the Likely Impact of a Rotavirus Vaccination Program in England: The Contribution of Syndromic Surveillance.
    Bawa Z; Elliot AJ; Morbey RA; Ladhani S; Cunliffe NA; O'Brien SJ; Regan M; Smith GE
    Clin Infect Dis; 2015 Jul; 61(1):77-85. PubMed ID: 25828997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rotavirus vaccines. WHO position paper – January 2013.
    Wkly Epidemiol Rec; 2013 Feb; 88(5):49-64. PubMed ID: 23424730
    [No Abstract]   [Full Text] [Related]  

  • 20. Change in incidence of clinic visits for all-cause and rotavirus gastroenteritis in young children following the introduction of universal rotavirus vaccination in Israel.
    Muhsen K; Chodick G; Goren S; Anis E; Ziv-Baran T; Shalev V; Cohen D
    Euro Surveill; 2015; 20(42):. PubMed ID: 26538450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.